Cargando…
Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress
SIMPLE SUMMARY: NRP-1, a co-receptor of the EGFR, represented an interesting candidate to investigate in HNSCC, as Cetuximab, in combination with radio and chemotherapy, provided the first targeted therapy scheme approved by the FDA as a standard of care for patients with recurrent or metastatic HNS...
Autores principales: | Napolitano, Virginia, Russo, Daniela, Morra, Francesco, Merolla, Francesco, Varricchio, Silvia, Ilardi, Gennaro, Di Crescenzo, Rosa Maria, Martino, Francesco, Mascolo, Massimo, Celetti, Angela, Tamagnone, Luca, Staibano, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345038/ https://www.ncbi.nlm.nih.gov/pubmed/34359721 http://dx.doi.org/10.3390/cancers13153822 |
Ejemplares similares
-
CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC
por: Morra, Francesco, et al.
Publicado: (2019) -
The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells
por: Morra, Francesco, et al.
Publicado: (2017) -
Tissue Expression of Carbonic Anhydrase IX Correlates to More Aggressive Phenotype of Basal Cell Carcinoma
por: Russo, Daniela, et al.
Publicado: (2021) -
HPV Virus Transcriptional Status Assessment in a Case of Sinonasal Carcinoma
por: Ilardi, Gennaro, et al.
Publicado: (2018) -
Epigenetics of oral and oropharyngeal cancers (Review)
por: Russo, Daniela, et al.
Publicado: (2020)